» Authors » Min-Ling Liu

Min-Ling Liu

Explore the profile of Min-Ling Liu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 77
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang H, Qileng A, Luo L, Wang Y, Huang S, Shen Y, et al.
Food Chem . 2025 Feb; 474:143243. PMID: 39951851
The tolerance advantages of nanobodies (Nbs) provide a new proposal for enhancing the stability and sensitivity of immunosensors. However, the tolerance of Nbs to extreme pH levels, has not been...
2.
Chien T, Lo H, Liu M, Hsu T, Lee S, Hsu W, et al.
Int J Med Mushrooms . 2025 Jan; 27(3):57-69. PMID: 39819523
Cordycepin, known for its tumor-suppressive and antiviral properties, has garnered attention due to its therapeutic and biological potential. Current Cordyceps militaris - based cordycepin production methods involve time-consuming and cost-intensive...
3.
Liu M, Chien T, Lo H, Hsu T, Lee S, Chao S
Int J Med Mushrooms . 2024 Jul; 26(8):59-73. PMID: 38967211
Cordyceps militaris, a medicinal fungus rich in cordycepin, shows promise in treating diseases such as cancer, respiratory issues, and COVID-19. This study examines the impact of different Taiwanese rice varieties...
4.
Liu M, Liang X, Jin M, Huang H, Luo L, Wang H, et al.
J Agric Food Chem . 2024 May; 72(19):10753-10771. PMID: 38706131
Food-borne biotoxins from microbes, plants, or animals contaminate unclean, spoiled, and rotten foods, posing significant health risks. Neutralizing such toxins is vital for human health, especially after food poisoning. Nanobodies...
5.
Chen K, Liu M, Wang J, Fang S
Biomol Biomed . 2023 Oct; 24(3):465-476. PMID: 37877819
Adoptive cell therapy (ACT) has been demonstrated to be one of the most promising cancer immunotherapy strategies due to its active antitumor capabilities in vivo. Engineering T cells to overexpress...
6.
Liu M, He X, Xu Z, Deng H, Shen Y, Luo L, et al.
J Agric Food Chem . 2023 Aug; 71(35):13137-13146. PMID: 37611148
A heavy-chain antibody (VHH) library against procymidone (PRM) was constructed via immunizing camels. Through careful biopanning, seven nanobodies (Nbs) with different sequences were obtained. The variability in their performance was...
7.
Liu M, Chen Z, Huang X, Wang H, Zhao J, Shen Y, et al.
Environ Pollut . 2023 Jul; 335:122265. PMID: 37517641
The simultaneous determination of carbaryl and its metabolite 1-naphthol is essential for risk assessment of pesticide exposure in agricultural and environmental samples. Herein, several bispecific nanobodies (BsNbs) with different lengths...
8.
DeRosa P, Roche K, Nava V, Singh S, Liu M, Agarwal A
Curr Oncol . 2022 Jul; 29(7):4587-4592. PMID: 35877223
Myelodysplastic syndromes (MDS) and Waldenstrom's macroglobulinemia (WM) are rarely synchronous. Ineffective myelopoiesis/hematopoiesis with clonal unilineage or multilineage dysplasia and cytopenias characterize MDS. Despite a myeloid origin, MDS can sometimes lead...
9.
Roche K, DeRosa P, Liu M, Nava V, Aggarwal A
Curr Oncol . 2022 Jun; 29(6):4117-4124. PMID: 35735437
Standard treatment regimens for the management of patients with refractory splenic marginal zone lymphoma (SMZL) are currently unavailable. Here, we report a case of SMZL, which, after failing multiple therapeutics,...
10.
Abdulbaki R, DeRosa P, Mobarek D, Liu M, Nava V
Br J Haematol . 2022 Feb; 197(1):8. PMID: 35141948
No abstract available.